Financhill
Sell
2

BDRX Quote, Financials, Valuation and Earnings

Last price:
$2.34
Seasonality move :
-21.69%
Day range:
$2.55 - $2.91
52-week range:
$2.55 - $92.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.73x
P/B ratio:
0.41x
Volume:
3.4M
Avg. volume:
1.9M
1-year change:
-94.4%
Market cap:
$2.2M
Revenue:
--
EPS (TTM):
-$25.93

Earnings Data

Next earnings date for BDRX
--
Most recent earnings per share
--
Missed by --
(Dec 31/2018)
Consensus Estimate
--
(Dec 31/2018)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

BDRX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
06/30/2019 Q2 -- -- -- -$208.17 --
03/31/2019 Q1 -- -- -- -$104.09 --
12/31/2018 Q4 -- -- -- -- --
09/30/2018 Q3 -- -- -- -$5,107.44 --
06/30/2018 Q2 -- -- -- -- --
03/31/2018 Q1 -- -- -- -$7,794.30 --
12/31/2017 Q4 -- -- -- -- --
09/30/2017 Q3 -- -- -- -$6,395.04 --
06/30/2017 Q2 -- -- -- -- --
12/31/2016 Q4 -- -- -- -- --
06/30/2016 Q2 -- -- -- -- --
12/31/2015 Q4 -- -- -- -- --

Biodexa Pharmaceuticals Plc Earnings Questions

  • How Much did Biodexa Pharmaceuticals Plc Generate in Revenue Last Quarter?

    Biodexa Pharmaceuticals Plc reported -- worth of top line sales in its most recent quarter.

  • Did Biodexa Pharmaceuticals Plc Beat Earnings Last Quarter?

    Biodexa Pharmaceuticals Plc announced earnings per share of -- which represents a miss of analyst forecast a -- per share.

  • Is Biodexa Pharmaceuticals Plc Profitable?

    Biodexa Pharmaceuticals Plc reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Biodexa Pharmaceuticals Plc EPS Next Year?

    Biodexa Pharmaceuticals Plc's earnings are forecast to decrease from -$148.23 per share to -$0.63 per share next year representing a decrease of -99.64%.

  • When is Biodexa Pharmaceuticals Plc's Earnings Date?

    Currently, Biodexa Pharmaceuticals Plc has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on March 31, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Is CoreWeave Stock Down So Much?
Why Is CoreWeave Stock Down So Much?

AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…

Why Did Stan Druckenmiller Buy MercadoLibre Stock?
Why Did Stan Druckenmiller Buy MercadoLibre Stock?

In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 65x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
72
GLTO alert for Dec 29

Galecto, Inc. [GLTO] is down 12.13% over the past day.

Sell
20
SMX alert for Dec 29

SMX (Security Matters) Plc [SMX] is down 27.67% over the past day.

Sell
11
CDNAF alert for Dec 29

Canadian Tire Corp. Ltd. [CDNAF] is up 11.94% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock